Clinical Trial Update: Plasma Biomarkers C-RAC, ICORG 12-27, V1

View source ↗

Summary

This document reports the termination of the ICORG 12-27 trial evaluating the plasma biomarker C-RAC in colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Cancer Trials Ireland | Conditions: Colorectal Cancer | Status: TERMINATED